跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
阿莫西林克拉维酸钾干混悬剂(7:1) - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin and Clavulanate Potassium for Oral Suspension(7:1)
Approved
化学药品
Amoxicillin and Clavulanate Potassium for Oral Suspension(7:1)
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jul 15, 2015
Approval ID
7LeagV7okqc
Company
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Type
化学药品
Approval Details
Approval Id
7LeagV7okqc
Approval Number
国药准字J20150096
Generic Name
阿莫西林克拉维酸钾干混悬剂(7:1)
Generic Name En
Amoxicillin and Clavulanate Potassium for Oral Suspension(7:1)
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
0.2285g(7:1)/包
Reg Date
2015-07-15
Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街1&8号澳美制药中心
Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 15, 2015
Approval ID
7LeagV7okqc
Type
化学药品
Back to NMPA Approvals